CryptoMedix Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $237K

CryptoMedix General Information

Description

Developer of proprietary technology for cancer and certain inflammatory diseases. The company is focused on the commercialization of a portfolio of biologics and diagnostic agents with the potential for cancer and certain inflammatory diseases.

Contact Information

Formerly Known As
CryptoMedix LLC
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 464 Basin Point Road
  • North Harpswell, ME 04079
  • United States
+1 (207) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CryptoMedix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - General 08-Jun-2016 $237K 00000 Completed Generating Revenue
To view CryptoMedix’s complete valuation and funding history, request access »

CryptoMedix Executive Team (4)

Name Title Board Seat Contact Info
Bernd Seizinger Ph.D Co-Founder, Executive Chairman, Acting Chief Executive Officer & Managing Director
Peter Brooks Ph.D Co-Founder & Chief Scientific Adviser
Leonard Liebes Ph.D Co-Founder, Board Member, Scientific Director & Chief Operations Manager
You’re viewing 3 of 4 executive team members. Get the full list »

CryptoMedix Board Members (4)

Name Representing Role Since
Bob Davis CryptoMedix Board Member 000 0000
Bob Suva CryptoMedix Board Member 000 0000
Leonard Liebes Ph.D CryptoMedix Co-Founder, Board Member, Scientific Director & Chief Operations Manager 000 0000
You’re viewing 3 of 4 board members. Get the full list »